RE: I think there is some bad news on way6 Jul 2022 20:53
100% disagree there.
Despite the current global situation there's too much money to be made from this royalty agreement for not just us but also our Chinese partners for them to start reneging on the deal which, shall I remind you is a full binding agreement....
"pleased to report that as planned we have completed detailed commercial negotiations and have entered into a full binding agreement that will enable us to bring our early cancer testing technology to this important market. Our Chinese partners will be financing all activities in China in exchange for providing us with important and repeatable royalty revenues and covering the costs for all key reagents and our proprietary monoclonal antibodies".
So if they chose to start reneging on it now there would be clauses written into the agreement whereby they would likely have to pay us financial penalties for pulling out of the binding agreement, which would only be bad for them not us, especially given that we are entering the US market with our partners there too.
Infact I think our Chinese partners may be looking to wrap things up quickly given that they know this product will soon be getting distributed and sold to the US, and perhaps even the UK and Europe once this is hopefully announced very soon.
So the way I see it, China would be biting off it's nose to spite it's face if it went back on it's binding agreement, due to the financial penalties it would incur plus their knowledge that the product will be rolled out globally elsewhere with or without them. So something tells me they'll be hanging around for this....